Max Healthcare Institute (MHIL) has signed a share purchase agreement (SPA) for the acquisition of a 100 percent stake in Starlit Medical Centre (SMCPL) to expand its footprints in tier-I and tier-II cities. The deal, facilitated through MHIL's subsidiary, Crosslay Remedies, involves an enterprise value of Rs 940 crore.
The acquisition encompasses a 17-storey hospital building situated on about 27 acres at Gomti Nagar in Lucknow is a tertiary care facility. It has National Accreditation Board for Testing and Calibration Laboratories (NABL) and National Accreditation Board for Hospitals & Healthcare Providers (NABH) accreditation. Further, it presently serves around 2,00,000 patients annually.
With this, the company will mark its entry into Lucknow, where it plans to bring medical programmes such as oncology, and organ transplants, as well as strengthen its existing programmes like orthopaedics, cardiac sciences, neurosciences, and renal sciences. Through its presence in the city, the company aims to bring quality healthcare to the people of Uttar Pradesh.
Previously, Starlit Medical had entered into a business transfer agreement with Sahara India Medical Institute for the purchase of its healthcare undertaking, including the 550-bed Sahara Hospital located in Lucknow.
At present, Max Healthcare operates 17 healthcare facilities spanning Delhi-NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Within its current network, it has 3,533 beds, and following this acquisition, the total bed count would reach around 4,083 beds.
